Archives for April 23, 2019

← 2019
T cell boosting therapy expands into oncology

T cell boosting therapy expands into oncology

By Maggie Lynch

US FDA grants orphan drug designation for Hyleukin-7, an immuno-oncology agent that boosts T cell production and functionality, for the treatment of ICL.